Skip to content
OpenCapital
Get started

Illumina ILMN Free cash flow

Free cash flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
Azenta logo
AzentaAZTA
$6.11M-12.7%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
-$47.73M-5.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$25.67M-25.4%
Revvity logo
RevvityRVTY
——
Guardant Health logo
Guardant HealthGH
——

Other financials

Income statement

See full
Revenue$1.1B+4.8%
Gross profit$721.0M+5.6%
Operating income$209.0M+27.4%
Net income$134.0M+2.3%
EPS (diluted)$0.87+6.1%

Balance sheet

See full
Cash & equivalents$1.1B-2.2%
Total debt$2.0B-3.0%
Total equity$2.7B+13.0%
Total assets$6.6B+6.1%

Cash flow

See full
Operating cash flow$289.0M+20.4%
CapEx$38.0M+18.8%

Valuation

See full
Market cap$26.6B+91.5%
Enterprise value$27.56B+83.6%
P/E31.2×+20.1×
P/S6.1×+2.8×

Profitability

See full
Gross margin66.2%-0.1pp
Operating margin19.4%—
Net margin19.4%+12.7pp
FCF margin22.2%+2.0pp

Returns & leverage

See full
Return on equity33.8%+23.9pp
Debt / equity0.8×-0.1×
Current ratio1.7×-0.1×

Where this comes from

Calculated from Illumina’s reported figures.

$289.0Mnet cash from operating−$38.0Mcapital expenditures=$251M

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's free cash flow?
Illumina (ILMN) reported free cash flow of $251M in Q1 2026.
How has Illumina's free cash flow changed year-over-year?
Illumina's free cash flow increased by 20.7% year-over-year, from $208M to $251M.
What is the long-term trend for Illumina's free cash flow?
Over 2 years (2023 to 2025), Illumina's free cash flow has grown at a 81.4% compound annual growth rate (CAGR), from $283M to $931M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.